JAMA Surgery : Presurgical Oral Tamoxifen vs Transdermal 4-Hydroxytamoxifen in DCIS

JAMA Network - Un podcast de The JAMA Network

Essayez BookBeat gratuitement pendant 60 jours

Profitez d'un univers entier d'audiolivres et d'e-books, allant des nouveautés aux classiques.

Sponsored

Interview with Seema A. Khan, MD, author of Presurgical Oral Tamoxifen vs Transdermal 4-Hydroxytamoxifen in Women With Ductal Carcinoma In Situ: A Randomized Clinical Trial. Hosted by Amalia Cochran, MD. Related Content: Presurgical Oral Tamoxifen vs Transdermal 4-Hydroxytamoxifen in Women With Ductal Carcinoma In Situ

Visit the podcast's native language site